At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Digital Cell Imaging System for live cell analysis under shear flow
Alameda, CA, December 10, 2018 - Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has launched the BioFlux DCIS Digital Cell Imaging System.
The BioFlux DCIS provides a complete solution for live cell imaging under physiological conditions. The easy-to-use cell imaging system been designed with advanced capabilities to simplify demanding cell-based imaging applications with convenience and flexibility. The BioFlux DCIS incorporates Fluxion’s patented Well Plate Microfluidic technology with a fully integrated microscopy system to enable high throughput shear flow assays.
The compact, integrated BioFlux DCIS system includes everything needed to start producing publication-quality data- imager, objectives, 2 cameras, fluorescence module, computer, and software. The BioFlux DCIS is available immediately.